Pharmaceutical companies

Pathologists, researchers, and external collaborators often work across different sites, organizations, and time zones. This makes achieving consistent image interpretation more challenging. Reliable image visualization is essential to support confident decision-making and reproducible results.

As digital pathology programs mature, quality control extends far beyond the physical slide. Image quality can be influenced by scanners, viewing software, image artifacts, and display performance. Manual quality checks become increasingly difficult to manage, creating the risk that issues remain undetected until later stages of the workflow.

Pharmaceutical organizations increasingly rely on image analysis, biomarker quantification, multiplex imaging, and AI-assisted workflows to support research and clinical development. These advanced applications require dependable digital infrastructure and confidence that images are displayed consistently across users and locations.

Many pharmaceutical companies work closely with contract research organizations (CROs), academic partners, and specialized pathology providers. Successful collaboration depends on secure image sharing, standardized workflows, and the ability to review cases efficiently regardless of organizational boundaries.